Site Search

... Despite its benefits, access to biomarker testing has not kept pace with the rate of innovation due in part to lack of coverage by private health insurance and Medicaid for needed testing. Senate Bill 2201 aims to enable more Rhode Islanders to benefit from biomarker testing, a ... Cancer Action Network (ACS CAN) in Rhode Island: "Biomarker testing and precision medicine are helping extend and improve lives by tailoring care and treatment to a person’s individual condition. Over the past many months, we have heard countless stories of the difficulties a patient ... and the Rhode Island Senate for approving this legislation. We urge the House to follow suit and also take this critical step towards reducing health inequities and improving cancer outcomes." For more information on precision medicine, cancer biomarkers, current barriers to biomarker ...